Triple therapy for acute myocardial infarction: Combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention

American Journal of Cardiology

Volumn 85, Issue 8 SUPPL. 1, 2000, Pages 10-16

  Herrmann, Howard C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL RESEARCH; CLINICAL TRIAL; CORONARY STENT; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 0034720131     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00817-1     Document Type: Article

References (33)

1. Lange R.A., Hillis L.D. Clinical debate should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? N Engl J Med. 335:1996;1311-1312.
2. Every N.R., Parsons L.S., Hlatky M., Martin J.S., Weaver W.D. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 335:1996;1253-1260.
3. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
4. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van'T Hof A.W., Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419.
5. Gusto IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-1628.
6. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691.
7. Berger A.K., Shulman K.A., Gersh B.J., Pirzada S., Breall J.A., Johnson A.E., Every N.R. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA. 282:1999;341-348.
8. Weaver W.D., Simes R.J., Betriu A., Grines C.L., Zijlstra F., Garcia E., Girinfeld L., Gibbons R.J., Ribero E.E., DeWood M.A., Ribichini F. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA. 278:1999;2093-2098.
9. Stone G.W. Primary stenting in acute myocardial infarction. Circulation. 97:1998;2482-2485.
10. Antoniucci D., Santoro G.M., Bolognese L., Valenti R., Trapani M., Fazzini P.F. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 31:1998;1234-1239.
11. Suryapranata H., van't Hof A.W.J., Hoorntje J.C.A., de Boer M.J., Zijlstra F. A randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 97:1998;2502-2505.
12. Rodriquez A., Bernardi V., Fernandez M., Maurecin C., Ayala F., Santaero O., Martinez J., Mele E., Roubin G.S., Palacios I., Ambrose J.A. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol. 81:1998;1286-1291.
13. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neill W.W., Morice M.C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 341:1999;1949-1956.
14. Lefkovits J., Ivanhoe R.J., Califf R.M., Bergelson B.A., Anderson K.M., Stoner G.L., Weisman H.F., Topol E.J. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) or acute and six-month outcome after PTCA for acute myocardial infarction. Am J Cardiol. 77:1996;1045-1051.
15. Miller J.M., Smalling R.M., Ohman E.M., Bode C., Betriv A., Kleinman N.S., Schildcrout J.S., Bastos E., Topol E.J., Califf R.M. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction. Am J Cardiol. 84:1999;779-784.
16. Neumann F.J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gowaz M., Kostrati A., Schomig A. Effect of glycoprotein IIb/IIIa receptor blocked on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 98:1998;2695-2701.
17. Neumann F.J., Zohlnhofer D., Fakhoury L., Ott I., Gowaz M., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade or platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 34:1999;1420-1426.
18. Brener S.J., Barr L.A., Burchenal J.E., Katz S., George B.S., Jones A.A., Cohen E.D., Gainey P.C., White H.J., Cheek H.B., Moses J.W., Moliterno D.J., Effron M.B., Topol E.J. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.
19. Montalscot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Maillard L, Pinton P. Abciximab associated with primary angioplasty and stenting in acute myocardial infarction: the ADMIRAL study, 30-day final results (abstract). Circulation 1999;100(suppl I):I-87.
20. Stone G.W. Stenting and IIb/IIIa receptor blockade in acute myocardial infarction an introduction to the CADILLAC trial . J Invas Cardiol. 10:(suppl B):1998;36B-47B.
21. Connor C.P. Overcoming thrombolytic resistance. J Am Coll Cardiol. 34:1999;1395-1402.
22. Ohman EM, Kleiman NS, Gacioch G, Worley SJ, Navetta FI, Talley JD, Anderson HV, Ellis SG, Cohen MD, Spriggs D, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction. Circulation 1997;95:846-854.
23. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, et al. Abciximab facilitates the rate and extent of thrombolysis. Circulation 1999;99:2720-2732.
24. Ohman EM. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000 (In Press).
25. The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction JAMA 1988;260:2849-2858.
26. Topol E.J., Califf R.M., George B.S., Kereiakes D.J., Abbotsmith C.W., Candela R.J., Lee K.L., Pitt B., Stack R.S., O'Neill W.W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 317:1987;581-588.
27. Simons ML, Arnold AER, Betriv A, DeBono DP, Col J, Dougherty FC, vonEssen R, Lambartz H, Lubsen J, Meier B. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;1:197-203.
28. SWIFT Trial Study Group. SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. Br Med J 1991;302:555-560.
29. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, Moreyra E, Traboulsi M, Racine N, Riba AL, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. J Am Coll Cardiol 1999;34:1954-1962.
30. DeLemos JA, Antman EM, Gibson M, McCabe CH, Giugliano RP, Murphy SA, Frey MJ, Van der Wieker R, Van de Werf F, Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation MI: a TIMI 14 analysis (abstract). Circulation 1999;100(suppl 1):I-649.
31. Herrmann HC, Moliterno DJ, Bode C, Betriu A, Lincoff AM, Ohman EM. Combination abciximab and reduced-dose reteplase facilitates early PCI in acute MI: results from the SPEED trial. Circulation 1999;100(suppl 1):I-188.
32. Matetzky S, Novikov M, Gruberg L, Freimark D, Feinberg M, Elian D, Novikov I, Di Segni E, Agranat O, Har-Zahav Y, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol 1999;34:1932-1938.
33. Brodie B.R., Stuckey T.D., Hansen C., Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 85:2000;13-18.